Precipio, Inc. Common Stock (PRPO) Stock Price

PRPOStock
$21.38+14.61%52W
Market Cap$38.27M
P/E—
PEG Ratio—
Div yield—
Beta1.45

PRPO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-34.91%
Price vs S&P 500 (4W)-18.89%
VGM Score59.89

PRPO Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q3 2023-$1.40-$1.04+25.71%(+$0.36)
Q2 2023-$2.00-$1.80+10.00%(+$0.20)
Q1 2023-$2.60-$2.60+0.00%(+$0.00)

PRPO Analyst Recommendations

Mar 2024
Apr 2024
May 2024
Jun 2024
4.14
4.14
4.14
4.14

Industry Peers — Lab Analytical Instruments(25)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
PRPOPrecipio, Inc. Common Stock
CAC1.4x31.6%44.1%-5.7%$21.38
AAgilent Technologies Inc.DCA6.6x5.4%53.9%22.2%$172.97
WATWaters CorpFCA9.4x6.0%50.9%7.1%$436.95
ILMNIllumina IncDDA8.8x6.0%66.4%19.5%$262.54
MTDMettler-Toledo InternationalDCA7.9x5.5%60.3%26.6%$1622.29
RVTYRevvity, Inc.DDA5.8x-5.5%55.0%12.3%$152.64
AVTRAvantor, Inc.CFA1.7x0.5%31.8%-4.7%$16.42
BIO.BBio-Rad Laboratories, Inc. Class BCDB3.7x0.3%51.9%1.8%$364.15
BIOBio-Rad Laboratories, Inc.Class ACDB3.7x0.3%51.9%1.8%$353.70
TXG10x Genomics, Inc. Class A Common StockFDA14.8x16.6%69.6%-14.3%$69.86
BRKRBruker CorporationDDB2.4x11.6%47.7%-1.5%$54.80

About Precipio, Inc. Common Stock

Precipio Inc develops blood cancer diagnostics designed to reduce misdiagnoses among office-based oncologists. The company operates CLIA-certified laboratories in Connecticut and Nebraska, offering diagnostic products including HemeScreen and IV-Cell to healthcare providers across the United States. Revenue is primarily generated from third-party payers.